A spectrum of ALK-positive histiocytosis, and metabolites as biomarkers for GvHD diagnosis and risk assignment

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NHL Pacific Division Preview 2026 1h 48m · 25 Sep 2026 · The Steve Dangle Podcast

NPR News: 09-24-2026 8PM EDT 4 min · 25 Sep 2026 · NPR News Now

Fletch, Vaughan & Hayley's Lil Bitta Pod - 25th September 2026 7 min · 25 Sep 2026 · ZM's Fletch, Vaughan & Hayley

Send Me To Sleep | Orchards 48 min · 25 Sep 2026 · Send Me To Sleep

Fletch, Vaughan & Hayley's Big Pod - 25th September 2026 1h 27m · 25 Sep 2026 · ZM's Fletch, Vaughan & Hayley

8PM ET 09/24/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded13 Jan 2022

Publisherfeeds.transistor.fm ↗

Handlerec:11742104

Show notes

On today’s podcast, we’ll explore the largest case series to date describing ALK-positive histiocytosis. The authors provide new insights on the disease and its treatment with ALK inhibitors, which can provide durable responses. We’ll also review with a study that pinpoints alpha-ketoglutaric acid as consistently elevated in pediatric chronic GvHD, and finds unique metabolomic patterns that appear to distinguish different GvHD subtypes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in